Bills Tracker
Bill page
Controlled Drugs (Procedure for Specification) Bill
Controlled Drugs (Procedure for Specification) Bill has completed 1st reading on 2 Jul 2026 in the House of Commons. Parliament currently lists 2nd reading as its current stage.
Current position
- Latest completed stage
- 1st reading2 Jul 2026
- Current stage
- 2nd reading
- House
- House of Commons
- Bill type
- Private Members' Bill (Presentation Bill)
- Last updated
- 14 Sep 2026
- Proposer / sponsor
- Matt Turmaine Proposer / sponsor · Labour · House of Commons
Parliamentary Calendar
Next scheduled stage
· House of Commons
Future parliamentary business can change at short notice.
View in Parliamentary CalendarWhat this bill is about
The Controlled Drugs (Procedure for Specification) Bill is intended to change the procedure for amending Schedule 2 to the Misuse of Drugs Act 1971, which lists controlled drugs. The bill’s available official material sets out that it focuses on how changes to that schedule are made, rather than introducing entirely new measures. It is a Private Members’ Bill introduced in the House of Commons and is still at an early stage, so more detailed provisions are not yet available in the sources provided.
What it would do
- Change the procedure for amending Schedule 2 to the Misuse of Drugs Act 1971.
- Schedule 2 is used to list controlled drugs, so the bill is about the mechanism for altering those listings.
- The bill does not yet have supporting official bill text or explanatory notes in the provided sources.
Bill journey
Matched Commons vote groups are shown inside the relevant stage where the stored dates allow a match.
-
1st reading 2 Jul 2026 · House of Commons
Related daily summaries
Published daily summaries where this bill appears in the day’s parliamentary or government business.
